These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20520295)

  • 1. Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response.
    Kobak KA; Leuchter A; DeBrota D; Engelhardt N; Williams JB; Cook IA; Leon AC; Alpert J
    J Clin Psychopharmacol; 2010 Apr; 30(2):193-7. PubMed ID: 20520295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative analysis between site-based and centralized ratings and patient self-ratings in a clinical trial of Major Depressive Disorder.
    Targum SD; Wedel PC; Robinson J; Daniel DG; Busner J; Bleicher LS; Rauh P; Barlow C
    J Psychiatr Res; 2013 Jul; 47(7):944-54. PubMed ID: 23562150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-rater reliability of the Hamilton Depression Rating Scale as a diagnostic and outcome measure of depression in primary care.
    Morriss R; Leese M; Chatwin J; Baldwin D;
    J Affect Disord; 2008 Dec; 111(2-3):204-13. PubMed ID: 18374987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of face-to-face and remote assessment of inter-rater reliability on the Hamilton Depression Rating Scale via videoconferencing.
    Kobak KA; Williams JB; Engelhardt N
    Psychiatry Res; 2008 Feb; 158(1):99-103. PubMed ID: 17961715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression.
    Wirz-Justice A; Bader A; Frisch U; Stieglitz RD; Alder J; Bitzer J; Hösli I; Jazbec S; Benedetti F; Terman M; Wisner KL; Riecher-Rössler A
    J Clin Psychiatry; 2011 Jul; 72(7):986-93. PubMed ID: 21535997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Face-to-face versus remote administration of the Montgomery-Asberg Depression Rating Scale using videoconference and telephone.
    Kobak KA; Williams JB; Jeglic E; Salvucci D; Sharp IR
    Depress Anxiety; 2008; 25(11):913-9. PubMed ID: 17941100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can people with nonsevere major depression benefit from antidepressant medication?
    Stewart JA; Deliyannides DA; Hellerstein DJ; McGrath PJ; Stewart JW
    J Clin Psychiatry; 2012 Apr; 73(4):518-25. PubMed ID: 22226407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the Hamilton Depression Rating Scale and the Montgomery-Asberg Depression Rating Scale in depressed elderly: a meta-analysis.
    Heo M; Murphy CF; Meyers BS
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):899-905. PubMed ID: 17911366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Site-Based Versus Central Ratings in a Study of Generalized Anxiety Disorder.
    Williams JB; Kobak KA; Giller E; Reasner DS; Curry L; Detke MJ
    J Clin Psychopharmacol; 2015 Dec; 35(6):654-60. PubMed ID: 26488677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
    Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment.
    Pope HG; Amiaz R; Brennan BP; Orr G; Weiser M; Kelly JF; Kanayama G; Siegel A; Hudson JI; Seidman SN
    J Clin Psychopharmacol; 2010 Apr; 30(2):126-34. PubMed ID: 20520285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term efficacy and safety of desvenlafaxine in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
    Kornstein SG; Jiang Q; Reddy S; Musgnung JJ; Guico-Pabia CJ
    J Clin Psychiatry; 2010 Aug; 71(8):1088-96. PubMed ID: 20797382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS study.
    Steinberg M; Munro CA; Samus Q; V Rabins P; Brandt J; Lyketsos CG
    Int J Geriatr Psychiatry; 2004 Feb; 19(2):144-50. PubMed ID: 14758580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suicidal thinking and behavior during treatment with sertraline in late-life depression.
    Nelson JC; Delucchi K; Schneider L
    Am J Geriatr Psychiatry; 2007 Jul; 15(7):573-80. PubMed ID: 17586782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
    Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR
    Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.